Skip to main content
OpenTrials

Clinical trial condition

Immunoblastic Lymphadenopathy

Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.

192 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Immunoblastic Lymphadenopathy trial results

Completed

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

NCT00666211

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
Locations
  • Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
  • Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
  • Tennessee Plateau Oncology Crossville, Tennessee, United States
View Trial Details
Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579

Conditions
AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
Locations
  • National Naval Medical Center Bethesda, Maryland, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Center for Cancer Research Bethesda, Maryland, United States
View Trial Details
Completed

Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma

NCT00589381

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
View Trial Details

Related conditions